|
|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-02
|
$712,729
|
$712,729
|
BASU, HIRAK
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Yale Cancer Center NCTN
|
5U10CA180826-02
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-15
|
$1,428,925
|
$171,471
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
3U10CA180864-01S1
|
$70,000
|
$9,800
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
5U10CA180864-02
|
$620,949
|
$86,933
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$2,620
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$109,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer
|
5R01CA157372-04
|
$528,829
|
$528,829
|
THAKUR, MATHEW
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Ou
|
ZIA CP010126 - 00580
|
$39,863
|
$1,993
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-02
|
$528,806
|
$26,440
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Validation of prognostic and pathway signatures in lethal prostate cancer
|
5U01CA157703-05
|
$454,043
|
$454,043
|
HALABI, SUSAN
|
DUKE UNIVERSITY
|
|
|
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
|
5R01CA155301-05
|
$346,053
|
$346,053
|
GANN, PETER
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$371,487
|
$29,719
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$371,487
|
$55,723
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$3,743
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$12,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$428,850
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133 - 10416
|
$65,326
|
$9,799
|
Freedman, Daryl
|
DCEG (NCI)
|
|
|
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
|
1R01CA183962-01A1
|
$625,180
|
$625,180
|
HERNANDEZ-BOUSSARD, TINA
|
STANFORD UNIVERSITY
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-02
|
$700,000
|
$52,500
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
3U10CA180858-02S1
|
$100,000
|
$5,000
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-02
|
$1,192,600
|
$59,630
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
USP22 Function in Advanced Prostate Cancer
|
1R01CA182569-01A1
|
$457,244
|
$457,244
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
|
5R01CA166084-03
|
$323,796
|
$161,898
|
HERSHMAN, DAWN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$8,125
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$6,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$810,053
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Urologic Oncology Research Training Grant
|
2T32CA082088-16
|
$246,134
|
$172,294
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,805,205
|
$180,520
|
Linehan, W. Marston
|
CCR (NCI)
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
5U54CA096300-13
|
$1,056,847
|
$211,369
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-29S1
|
$89,185
|
$19,621
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-29
|
$1,485,000
|
$326,700
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
$17,861
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
$548,785
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$43,513
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$13,746
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$7,517
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$22,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$168,850
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-03S1
|
$250,000
|
$32,500
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-03S2
|
$125,000
|
$16,250
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
5P30CA177558-03
|
$1,505,000
|
$195,650
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S1
|
$114,745
|
$6,885
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S3
|
$177,700
|
$10,662
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-16
|
$1,361,692
|
$81,702
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-02
|
$692,055
|
$69,206
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S5
|
$1,213,480
|
$84,944
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S6
|
$48,256
|
$3,378
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
Understanding the Effects of Prostate Cancer on Gay and Bisexual Men
|
5R21CA182041-02
|
$165,300
|
$165,300
|
ROSSER, B. R. SIMON
|
UNIVERSITY OF MINNESOTA
|
|
|
Understanding Resistance to Next Generation Antiandrogens
|
5R01CA155169-04
|
$372,919
|
$372,919
|
SAWYERS, CHARLES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Total relevant funding to Prostate for this search: $228,871,655
|
